Mumbai: Pharmaceutical firm Suven Life Sciences Wednesday said it will raise $50 million through the issue of securities.
The shareholders of the company have approved to raise $50 million by issuing American Depository Receipts, Global Depository Receipts and Foreign Currency Convertible Bonds or convertible securities or other debt instruments, Suven Life Sciences said in a regulatory statement.
